AzTrials
AzTrials

Research institution

University Hospital, Antwerp Clinical Trials

Studies where University Hospital, Antwerp is the lead sponsor: what is enrolling now, by phase, condition and country.

242 registered studies

In numbers

Open to volunteers
56
Active
65
With results posted
4
All registered
242

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 56

Completed, with results posted

All 4
  • Infertility Unexplained, Infertility, Male

    Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle

    • Completed
    • Age: 18 to 65 years
    • Results posted

    Infertility affects about 10% of all couples and is defined by a failure to achieve a clinical pregnancy within a year of regular unprotected sexual intercourse.

    Conditions
    Infertility Unexplained, Infertility, Male, DNA Damage
    Trial name
    NCT03319654
    Testing
    DNA fragmentation by TUNEL assay
    Where
    Belgium
    Volunteers
    120 people, healthy volunteers welcome
    Sponsor
    University Hospital, Antwerp
    Can I take part? NCT03319654
  • Obesity, Atherosclerosis

    Endothelial Dysfunction in Obese Children

    • Completed
    • Age: 12 to 18 years
    • Lifestyle or therapy programme
    • Results posted

    The purpose of this study is to objectify the effect of diet and exercise on early markers of atherosclerosis in obese children.

    Trial name
    EDOC (NCT01461226)
    Testing
    Exercise training, Usual care
    Where
    3 sites in Belgium
    Volunteers
    61 people
    Sponsor
    University Hospital, Antwerp
    Can I take part? EDOC
  • Traumatic Brain Injury

    CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI

    • Completed
    • Age: All ages
    • Observational study
    • Results posted

    The research aims of the CENTER-TBI study are to: 1. better characterize Traumatic Brain Injury (TBI) as a disease and describe it in a European context, and 2. identify the most effective clinical interventions for managing TBI.

    Trial name
    CENTER-TBI (NCT02210221)
    Where
    65 sites in Austria, Belgium and 17 more
    Volunteers
    4,559 people
    Sponsor
    University Hospital, Antwerp
    Can I take part? CENTER-TBI
  • Diaphragmatic Dysfunction, Muscle Weakness

    Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex

    • Completed
    • Age: 18 years and older
    • Phase 3
    • Results posted

    The effect of neuromuscular blocking agents (NMBA, e.g. rocuronium) on respiratory muscle activity is well known. However, since the availability of sugammadex, to our knowledge, no study has been conducted to evaluate the effect…

    Conditions
    Diaphragmatic Dysfunction, Muscle Weakness, Muscle Fatigue
    Trial name
    SUDIA (NCT01962298)
    Testing
    sugammadex 2mg/kg, neostigmine, sugammadex 4mg/kg
    Where
    Belgium
    Volunteers
    75 people
    Sponsor
    University Hospital, Antwerp
    Can I take part? SUDIA

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in